← Back to Search

Behavioural Intervention

Exercise Program for Breast Cancer Survivors (B-REP Trial)

N/A

Waitlist Available

Led By Angela Fong, PhD

Research Sponsored by University of Michigan Rogel Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women who have a confirmed diagnosis of breast cancer, Stage 0I to IIIA

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks after start of intervention

Awards & highlights

B-REP Trial Summary

This trial will test a 12-week intervention to help Black breast cancer survivors with health outcomes. 60 people will be studied with assessments before and after the intervention.

Who is the study for?

This trial is for Black or African American women over 18 who've had breast cancer stages 0I to IIIA and finished primary treatment within the last 5 years. They should not be currently meeting exercise guidelines, but can't join if they have metastatic disease, are pregnant, planning surgery, moving out of the US during the study period, or unable to increase exercise safely.Check my eligibility

What is being tested?

The B-REP study compares a health education control with a personalized 12-week exercise program for Black breast cancer survivors. Participants will be randomly placed in one of these two groups and assessed at the start, after 12 weeks (post-intervention), and after another three months.See study design

What are the potential side effects?

Since this trial involves an individualized exercise program rather than medication, side effects may include typical exercise-related issues such as muscle soreness or strain. The eligibility criteria ensure participants can safely increase physical activity.

B-REP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman diagnosed with breast cancer at an early to mid-stage (0I to IIIA).

B-REP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks after start of intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks after start of intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after start of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Affective attitude

Feasibility of the exercise program (Adherence)

Feasibility of the exercise program (Retention)

+4 more

B-REP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (Supervised exercise)Experimental Treatment1 Intervention

The individualized resistance exercise program is based on participants' baseline 1-repetition maximum muscular strength assessment (i.e., the maximum lifted for 1 repetition) and is aligned with current cancer-specific exercise recommendations. The resistance exercise program will follow the FITT principle (frequency, intensity, time, and type). Sessions will be 35-45 minutes in duration.

Group II: ControlActive Control1 Intervention

Participants randomized to health education control condition will receive the American Cancer Society Physical Activity and the Person with Cancer summary for patients and American College of Sports Medicine Exercise is Medicine Effects of Exercise on Health-Related Outcomes in Those with Cancer infographic

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor

294 Previous Clinical Trials

24,061 Total Patients Enrolled

33 Trials studying Breast Cancer

3,988 Patients Enrolled for Breast Cancer

Angela Fong, PhDPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center

1 Previous Clinical Trials

56 Total Patients Enrolled

1 Trials studying Breast Cancer

56 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available in this clinical trial for participants?

"Unfortunately, this trial is not actively recruiting according to clinicaltrials.gov records as it was last updated on October 20th, 2023 and first posted April 1st 2024. Nonetheless, there are over two thousand four hundred thirty-nine (2439) other trials currently accepting participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breast Cancer Resiliency Through Exercise Program (B-REP)

2024. "Breast Cancer Resiliency Through Exercise Program (B-REP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06100263.